EGFR, MUTATIONAL ANALYSIS

Patients positive for EGFR mutations benefit from Tyrosine kinase inhibitors (Gefitinib). This assay detects insertions / deletions in codons 19 and 20. It also detects the most common mutations in codons 18, 19, 20 and 21.

  • Test Type:
  • Pre-test Information:
    Provide a copy of the Histopathology report. Indicate site of biopsy and provide clinical history
  • Report Delivery:
    Sample by Mon/ Thu 9 am; Report Fri/ Tue Sample by Mon/ Thu 9 am; Report Fri/ Tue
  • Components:
    0

Sample Report